Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/17/2008
 
First Published:
9/23/2006
1.
Phase II Study of 3-AP (Triapine®) Followed By Fludarabine Phosphate in Patients With Myeloproliferative Disorders or Chronic Myelomonocytic Leukemia in Aggressive Phase or Transformation or Chronic Myelogenous Leukemia in Accelerated Phase or Blast Crisis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
JHOC-J0638
7704, NCI-7704, NCT00381550
Last Modified:
5/20/2008
 
First Published:
2/10/2006
2.
Phase I Study of 3-AP (Triapine®) and Gemcitabine Hydrochloride in Patients With Advanced Solid Tumors or Lymphomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
OSU-05016
OSU-2005C0031, NCI-7043, 7043, NCT00293345
Last Modified:
1/2/2007
 
First Published:
1/25/2006
3.
Phase I Study of 3-AP (Triapine®) and Radiotherapy in Patients With Unresectable Stage III Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
OSU-05011
OSU-2005C0030, NCI-7044, 7044, NCT00288093
Last Modified:
7/16/2008
 
First Published:
10/14/2006
4.
Phase I Study of 3-AP in Patients With Advanced or Metastatic Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
CCC-PHI-52
CHNMC-PHI-52, 7225, NCT00390052
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute